Literature DB >> 28721699

Bypass of confirmatory tests for case detection of primary aldosteronism in leaner patients?

Konstantinos Stavropoulos1, Konstantinos P Imprialos1, Michael Doumas2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28721699      PMCID： PMC8030772          DOI： 10.1111/jch.13039

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  13 in total

1.  Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.

Authors:  Stella Douma; Konstantinos Petidis; Michael Doumas; Panagiota Papaefthimiou; Areti Triantafyllou; Niki Kartali; Nikolaos Papadopoulos; Konstantinos Vogiatzis; Chrysanthos Zamboulis
Journal:  Lancet       Date:  2008-06-07       Impact factor: 79.321

Review 2.  Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis.

Authors:  Sabine C Käyser; Tanja Dekkers; Hans J Groenewoud; Gert Jan van der Wilt; J Carel Bakx; Mark C van der Wel; Ad R Hermus; Jacques W Lenders; Jaap Deinum
Journal:  J Clin Endocrinol Metab       Date:  2016-05-12       Impact factor: 5.958

Review 3.  Clinical Value of Measuring the Renin/Aldosterone Levels: Optimising the Management of Uncontrolled/Resistant Hypertension.

Authors:  Michalis Doumas; Chrysoula Boutari; Costas Tsioufis; Kyriakos Dimitriadis; Areti Triantafyllou; Stella Douma
Journal:  Curr Vasc Pharmacol       Date:  2017       Impact factor: 2.719

4.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

5.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

6.  Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.

Authors:  Sébastien Savard; Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Hypertension       Date:  2013-06-10       Impact factor: 10.190

7.  Obesity and the diagnostic accuracy for primary aldosteronism.

Authors:  Amit Tirosh; Fady Hannah-Shmouni; Charalampos Lyssikatos; Elena Belyavskaya; Mihail Zilbermint; Smita B Abraham; Maya B Lodish; Constantine A Stratakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-06-13       Impact factor: 3.738

8.  Unadjusted Plasma Renin Activity as a "First-Look" Test to Decide Upon Further Investigations for Primary Aldosteronism.

Authors:  Peter Rye; Alex Chin; Janice Pasieka; Benny So; Adrian Harvey; Gregory Kline
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-10       Impact factor: 3.738

9.  Screening for Primary Aldosteronism: Whom and How?

Authors:  Michael Doumas; Vasilios Athyros; Vasilios Papademetriou
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-10       Impact factor: 3.738

10.  Primary hyperaldosteronism in patients with resistant hypertension may be less prevalent than previously reported: evidence against an epidemic.

Authors:  Michael J Bloch; Jan N Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-08       Impact factor: 3.738
View more
  2 in total

1.  Bypass of confirmatory tests for case detection of primary aldosteronism in leaner patients?

Authors:  Konstantinos Stavropoulos; Konstantinos P Imprialos; Michael Doumas
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-07-18       Impact factor: 3.738

2.  Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?

Authors:  Konstantinos Stavropoulos; Konstantinos P Imprialos; Niki Katsiki; Konstantinos Petidis; Apostolos Kamparoudis; Panagiotis Petras; Vasiliki Georgopoulou; Stefanos Finitsis; Christodoulos Papadopoulos; Vasilios G Athyros; Michael Doumas; Asterios Karagiannis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-02       Impact factor: 3.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.